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Abstract
We tested the hypothesis that membrane lipid composition influences drug action at membrane proteins by studying local anesthetic action at the nicotinic acetylcholine receptor (nAChR).
Infrared difference spectra show that concentrations of tetracaine consistent with binding to the ion channel (<50 µM) stabilize a resting-like state when the nAChR is reconstituted into phosphatidylcholine membranes containing the anionic lipid, phosphatidic acid, but have no effect on the nAChR reconstituted into membranes lacking phosphatidic acid, either in the presence or absence of cholesterol. Concentrations of tetracaine above 200 µM lead to neurotransmitter site binding in all membranes. In the presence of phosphatidic acid and/or cholesterol, neurotransmitter site binding leads to the formation of quaternary amine-aromatic interactions between tetracaine and binding site tyrosine/tryptophan residues and the stabilization of a desensitized state. One interpretation suggested by lipid partitioning studies is that phosphatidic acid enhances tetracaine action at the channel pore by increasing the partitioning of tetracaine into the lipid bilayer and thus enhancing access to the transmembrane pore. Subtle membrane-dependent variations in the vibrations of tyrosine and tryptophan residues, as well as agonist analog binding studies, however, indicate that the structures of the agonist-bound neurotransmitter sites of the nAChR in membranes lacking both phosphatidic acid and cholesterol differ from the structures of the agonist-desensitized neurotransmitter sites in the presence of both lipids. Lipid action at the nAChR thus involves more than a simple modulation of the equilibrium between resting and desensitized states.
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Introduction
Many of the complex and diverse functions of biological membranes are intimately dependent upon the interactions that occur between lipids and proteins. Numerous integral membrane proteins, including the nicotinic acetylcholine receptor, are dependent upon lipid bilayer composition for optimal activity (Lee, 2004; Barrantes, 2002 Barrantes, , 2004 . Membrane protein function can be regulated by the association of proteins with lipid microdomains/rafts (Allen et al., 2007; Szabo et al., 2007) . Conversely, numerous proteins can influence the physical properties and/or the two-dimensional packing of lipids in a biological membrane (McMahon and Gallop, 2005; daCosta et al., 2002) .
Given the intimate relationship between both lipid and membrane protein structure and function, it seems likely that lipid bilayers influence drug action at membrane protein targets. It has been suggested that drug induced perturbations in bulk membrane physical properties/fluidity may alter membrane protein function, although in many cases protein binding sites for lipophilic drugs have been identified (Miller, 2002) . Alternatively, drugs could indirectly influence membrane protein activity by disrupting the formation of and/or association of proteins with lipid rafts (Szabo et al., 2007) . Changes in lipid composition, as a protein target shuttles in and out of a raft, or as a consequence of diet, etc., could also influence drug action by stabilizing the target protein in conformations that bind drugs with different affinities. Given that over 50% of all drug targets are membrane proteins, understanding how drug action is influenced by the lipid bilayer is clearly of importance (Overington et al., 2006) .
In this report, we use Fourier transform infrared (FTIR 1 ) difference spectroscopy to examine how lipid environment influences the ability of a local anesthetic to modulate the conformational equilibria of the nicotinic acetylcholine receptor (nAChR 1 ) from the electric fish MOL 39008
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Torpedo. The nAChR is the prototype of the Cys-loop family of neurotransmitter-gated ion channels, whose members are found at synapses throughout the peripheral and central nervous systems Lester et al., 2004) . The nAChR is an excellent model for testing how lipids influence drug action because it has been used extensively for independently studying both lipid-protein and drug-receptor interactions (Arias et al., 2006; Ryan et al., 1996; Baenziger et al., 2000; Fong and McNamee, 1986) .
We first examine the conformational effects of the local anesthetic, procaine, at the nAChR to test the utility of the spectroscopic technique for monitoring local anesthetic induced conformational change. We chose to study this local anesthetic because its effects on nAChR conformational state are unclear (Krodel et al., 1979) . Most local anesthetics bind to mutually exclusive non-competitive inhibitor sites in the channel pore and are thought to stabilize the nAChR in a desensitized conformation. Procaine, unlike most local anesthetics, binds with higher affinity to the neurotransmitter sites (K D = 930 µM) than to its allosteric non-competitive inhibitor site in the ion channel (K D = 3000 µM) (Blanchard et al., 1979) . As procaine competes directly with acetylcholine for binding, acetylcholine binding assays have not detected a procaine-induced change in acetylcholine binding affinity associated with the stabilization of either a resting or desensitized state. Our goal here was to test whether FTIR difference spectroscopy, which monitors directly ligand-induced nAChR structural change, can detect a procaine-induced conformational shift that has not been detected using classical ligand-binding experiments.
We next examine the conformational effects of the local anesthetic, tetracaine, on the nAChR reconstituted into membranes composed of phosphatidylcholine (PC) either with or without phosphatidic acid (PA) and/or Cholesterol (Chol). The specific membrane environments MOL 39008 6 were chosen because of their varying abilities to stabilize the nAChR in a functional state (Baenziger et al., 2000) . The local anesthetic, tetracaine, was chosen because it has complex effects at the nAChR. Tetracaine binds to its allosteric non-competitive inhibitor site in the channel pore (K D = 1.5 µM) where it stabilizes the nAChR in a low affinity agonist binding and thus putative resting conformation (Blanchard et al., 1979, Boyd and Cohen, 1980) . Tetracaine also binds at higher concentrations (K D = 800 µM) to the neurotransmitter sites and stabilizes a desensitized state (Blanchard et al., 1979, Ryan and Baenziger, 1999) .
Our results show that the ability of tetracaine to modulate nAChR conformational equilibria is dependent upon lipid environment. Drug action at the nAChR and possibly other neurotransmitter receptors is sensitive to membrane lipid composition. Our data demonstrate the utility of FTIR difference spectroscopy for monitoring drug action at membrane protein targets and provide insight into the mechanisms by which lipids alter drug action at the nAChR.
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Materials and Methods
Materials. Electric tissue from Torpedo californica was purchased from Aquatic
Research Consultants (San Pedro, CA). Tetracaine, procaine, carbamylcholine (Carb), and cholesterol (Chol) were from Sigma-Aldrich (St. Louis, MO). Egg phosphatidylcholine (referred to as PC) and dioleoylphosphatidic acid (referred to as PA) were from Avanti polar lipids (Alabaster, Al).
Sample Preparation. The nAChR was affinity purified and reconstituted into membranes composed of either PC, PC/Chol 3:2 (mol/mol), PC/PA 3:2 (mol/mol), and PC/PA/Chol 3:1:1 (mol/mol/mol) as described in detail elsewhere (daCosta et al., 2002) . The affinity purifications were performed using a derivatized Affi-Gel 102 (Bio-Rad, Hercules, CA) column prepared as follows. 10-15 mls of Affi-Gel 102 was incubated with 3.5 g of N-acetyl-DLhomocysteinethiolactone overnight at pH 9.7 to generate a sulfhydryl reactive group. The following morning, the gel was washed extensively with 0.1 M NaCl and incubated with 25 mls of 0.08 M dithiothreitol (Sigma, St. Louis, MO) in 200 mM Tris, pH 8. After 30 minutes, the gel was washed with 100mM NaCl in 20 mM Na 2 HPO 4 to remove all dithiothreitol and the activated resin reacted with 0.4 g of bromoacetylcholine bromide in 15 mls of 50 mM Na 2 HPO 4, pH 7 for one hour. The gel was then washed with several column volumes of 200 mM Tris, pH 8 and incubated with 0.1 g of iodoacetamide to block remaining free sulfhydryl groups.
Aliquots for analysis by FTIR were prepared by depositing 250 µg of nAChR protein in the chosen lipid environment on the surface of a germanium internal reflection element (see Fig.   1 , supplemental information). In each case, the excess buffer was evaporated with a gentle stream of N 2 gas and the nAChR film rehydrated with excess Torpedo Ringer buffer (250 mM MOL 39008 8 NaCl, 5 mM KCl, 2 mM MgCl 2 , 3 mM CaCl 2 , and 20 mM Tris, pH 7.0). Each sample was placed in a thermostatically controlled attenuated total reflection cell (Harrick Scientific;
Ossining, New York).
FTIR Spectroscopy. All infrared spectra were acquired using the attenuated total reflectance (ATR) technique on either an FTS-40 or an FTS-575 spectrometer equipped with a DTGS detector. Spectra were recorded at 8 cm -1 resolution using 512 scans each, which took roughly 7 minutes per spectrum. Consecutive spectra of the resting nAChR were recorded while flowing Torpedo Ringer buffer past the nAChR film surface. The flowing solution was then switched to an identical buffer containing 50 µM Carb and a spectrum recorded of the desensitized state. The difference between the two resting state spectra (control spectra) and the consecutive resting and desensitized state spectra (referred to as a Carb difference spectrum)
were calculated, stored, and the flowing solution switched back to buffer without Carb. After a 20 minute washing period to remove Carb from the film, the process was repeated many times.
The effects of procaine and tetracaine on the structure of the nAChR were probed by recording Carb difference spectra as described above while maintaining the nAChR in the continuous presence of the local anesthetic (the local anesthetic was included in both the plus and minus Carb buffers). For each tetracaine concentration, Carb difference spectra were recorded from a minimum of two different nAChR films. Each presented difference spectrum is the average of more than 40 individual difference spectra. Spectra were interpolated to a resolution of 4 cm -1 and were baseline corrected between 1760 and 1500 cm -1 .
Dose response curves. Dose response curves were calculated by measuring band intensities in each spectrum relative to the same band intensities observed in the absence and presence of "saturating" concentrations of local anesthetic. For each band, its intensity in a MOL 39008
given spectrum was measured relative to an adjacent baseline point. For example, the band intensities at both 1545 and 1515 cm -1 were measured in each spectrum relative to the baseline at 1527 cm -1 . Data are plotted as the percent change in intensity. The positive bands at 1655, 1545, and 1515 cm -1 , and the negative band near 1620 cm -1 decrease in intensity in the presence of the local anesthetic, so the 100% value refers to the intensity of the band in spectra recorded in the absence of local anesthetic and the 0% value refers to the intensity of the same band in spectra recorded at the highest local anesthetic concentration. The positive band at 1663 and the negative bands at 1605, and 1273 cm -1 first appear and then increase in intensity with the addition of local anesthetic, so the 100% and 0% values correspond to the intensities in spectra recorded at the highest concentration of local anesthetic and in the absence of local anesthetic, respectively. Data were analyzed using a sigmoidal dose-response curve in Graph Pad Prism version 4 (see Table 1S of supplemental information). Except where noted, each EC 50 value presented in Table 1 Note that each spectrum used to generate a difference band intensity at a given local anesthetic concentration is the average of between 30 and 60 individual difference spectra and thus 30 to 60 separate experiments. This large number of experiments is necessary to obtain spectra with sufficient signal-to-noise ratio and takes at least two days of spectrometer time.
Consequently, it is not feasible to obtain spectra at the number of local anesthetic concentrations This article has not been copyedited and formatted. The final version may differ from this version. Table 1S of the supplemental information.
Tetracaine Partitioning into lipid bilayers. The partition coefficient of tetracaine into each membrane environment was determined as described by Romsicki and Sharom, 1999. Briefly, duplicate membranes at a lipid concentration of 10 mg/ml were equilibrated with 100 µM tetracaine at 22 ºC for 24 hours under constant gentle stirring. The samples were then pelleted at 36000g for 40 min at 22 ºC. The tetracaine remaining in the supernatant was determined by measuring the absorbance at 310 nm. Partition coefficients were defined as described in Table 2 .
This article has not been copyedited and formatted. The final version may differ from this version. Under careful data acquisition conditions, however, the difference between spectra recorded from a protein stabilized in two different conformational states will reveal bands from only those residues whose molecular vibrations, and thus local structures, change during the conformational transition (Vogel and Siebert, 2003, Kötting and Gerwert, 2005) . Difference spectroscopy provides detailed insight into the nature of protein conformational change at the single residue level. For example, the technique has detected changes in the protonation state and/or hydrogen bonding of individual residues during the light activated photocycles of bacteriorhodopsin and the photoactive yellow protein, etc. (Brudler et al., 2001, Kötting and Gerwert, 2005) . The detected changes in hydrogen bonding, etc., are often observed at a resolution not achievable with techniques, such as X-ray crystallography.
The difference between infrared spectra of the nAChR recorded in the presence and absence of the agonist, carbamylcholine, (a "Carb difference spectrum"), exhibits a number of overlapping positive and negative bands (Figs. 1-6 ). These bands are absent in the difference MOL 39008 between two spectra of the nAChR recorded both in the absence of ligand (data not shown, but see Hill and Baenziger, 2006) . They are also absent in control Carb difference spectra recorded from nAChR membranes that have been pre-treated with the competitive antagonist, α-bungarotoxin (Baenziger et al., 1993) . These control studies show that the detected vibrational difference bands arise specifically from the structural changes induced in the nAChR upon Carb binding. Only those receptors that are accessible to Carb are thus probed in this assay. Parallel functional studies show that the nAChR in similar films undergoes Carb-induced desensitization (Baenziger et al., 1992) . Positive and negative difference bands thus provide a vibrational map of the structural changes that occur in the nAChR upon Carb binding and the resting to desensitized conformational change.
Of particular interest are difference bands in the amide I (1640 to1670 cm -1 ) and amide II (1520 to 1580 cm -1 ) regions ( Mantsch, 1995) . Previous studies have shown that these difference bands reflect a change in both the orientation and hydrogen bonding of a region (or regions) of the polypeptide backbone that is (or are) highly accessible to aqueous solvent (Baenziger and Chew, 1997; Hill and Baenziger, 2006) . Given both the relatively large changes in structure that occur upon ligand binding to the binding site "C-loop" and the relative solvent accessibility of this region of the polypeptide backbone, it was suggested previously that the vibrational changes that result from the closing of the C-loop around Carb upon transition from the unliganded resting to the liganded This article has not been copyedited and formatted. The final version may differ from this version. (Hill and Baenziger, 2006) . Regardless, these noted bands serve as markers of the ability of the nAChR to undergo the resting to desensitized conformational transition (Ryan et al., 1996) . The negative and positive bands centered near 1620 cm -1 and 1515 cm -1 , respectively, are characteristic of tryptophan and tyrosine side chains, respectively (Barth, 2000) . A previous study suggested that these vibrational bands appear upon binding and the formation of physical interactions between Carb and aromatic residues (Ryan and Baenziger, 1999) . As several aromatic residues are located in the binding site (Unwin, 2005; Zhong et al., 1998) , the changes in band intensity at these two frequencies may result from the formation of cation-π electron interactions between Carb and binding site tryptophan and tyrosine residues. Here, we use these four vibrations to assess both the nature of Carb-nAChR interactions in each membrane
This article has not been copyedited and formatted. The final version may differ from this version. Finally, bands in the difference spectrum near 1724 and 1473 cm -1 have been assigned to the vibrations of nAChR-bound Carb (Baenziger et al., 1993) . The absolute intensities of these vibrations are essentially constant in difference spectra recorded from sample to sample when spectra are recorded at saturating concentrations of Carb. This is because the multilamellar nAChR films extend well beyond the penetration depth of the evanescent wave of the infrared radiation (see supplemental Figure 1S ). recorded at 0, 100 µM, and 6 mM procaine (Fig. 1B) . The dose dependences of the spectral changes are plotted in Figure 1C with the corresponding values of EC 50 listed in Table 1 .
Conformational effects of procaine on the nAChR in PC/
The procaine-induced changes in the intensities of the amide I and II "marker" bands suggest that procaine does induce a conformational shift in nAChR equilibrium. Specifically, there are dose dependent decrease in intensity centered near 1655 and 1663 cm -1 leading to the This article has not been copyedited and formatted. The final version may differ from this version. appearance of the underlying negative band centered near 1668 cm -1 (this is the negative couple of the 1690 cm -1 difference band noted above). The loss of amide I intensity is coupled to a decrease in amide II band intensity centered near 1545 cm -1 . These spectral changes are essentially identical to those that have been observed in Carb difference spectra recorded in the presence of the desensitizing local anesthetic, dibucaine (Ryan and Baenziger, 1999) . The loss of intensity indicates that the nAChR does not undergo a Carb-induced transition from the resting to the desensitized state in the presence of procaine, likely because procaine already stabilizes a desensitized nAChR.
Note that the spectral changes suggestive of desensitization occur concomitant with the appearance of new negative bands at frequencies that match the vibrations of procaine itself (one of these at 1605 cm -1 is designated with a dashed line in Fig. 1B ). The negative procaine vibrations appear because procaine bound to the neurotransmitter sites is displaced upon Carb binding (see lower schematic in supplemental Fig. 1S B) . The increased negative intensity with increasing procaine concentration reflects increased binding of procaine to the neurotransmitter sites and provides a means of assessing the affinity of procaine for the neurotransmitter sites (Fig. 1C) .
The spectral changes indicative of procaine binding also occur concomitant with a reduction in the intensities of both the negative and positive bands near 1620 cm -1 and 1515 cm -1 , although the latter shifts up in frequency to 1516 cm -1 in the presence of procaine. As noted, these two bands are characteristic of tryptophan and tyrosine residues, respectively (Barth, 2000) , and likely reflect the formation of cation-π electron interactions between Carb and binding site aromatic residues. Procaine binding to the neurotransmitter sites may reduce the intensities near 1620 and 1515 cm -1 in Carb difference spectra by forming similar, but weaker, This article has not been copyedited and formatted. The final version may differ from this version. cation-π electron interactions with the same binding site tyrosine and tryptophan residues prior to Carb binding.
Note that at high concentrations of procaine, the loss of the positive amide I bands near 1663 and 1655 cm -1 reveals the underlying intensity of the negative protein side chain vibration near 1668 cm -1 , which is coupled to the positive side chain vibration near 1690 cm -1 . The intensities and frequencies of these two bands are essentially identical to those of the two bands in Carb minus tetramethylamine difference spectra (Ryan et al., 2000) , where the vibrations of the two bands can also been seen clearly due to the absence of overlapping amide I vibrations.
As noted, the 1690 and 1668 cm -1 bands reflect a vibrational shift in an as yet unidentified residue that interacts directly with the ester carbonyl of Carb (Ryan et al., 2000) . The fact that procaine binding to the neurotransmitter site has no effect on the frequencies or intensities of these two bands shows that although procaine interacts with aromatic residues in the neurotransmitter sites, it does not form a hydrogen bond with the residue that typically interacts with the ester carbonyl of Carb. The presence of an aromatic moiety on procaine adjacent to the ester carbonyl (Fig. 1C of supplemental information) must sterically prevent procaine from binding effectively to the "esterophilic" subsite in the neurotransmitter binding site.
The different vibrational changes indicative of procaine binding to the neurotransmitter sites appear with an EC 50 of 590 µM, which is essentially equivalent to the EC 50 for the procaineinduced changes in nAChR conformational state (540 µM; Table 1 ) and similar to the reported affinity of procaine for the neurotransmitter binding sites (K D = 930 µM) (Blanchard et al., 1979) . The FTIR data show that procaine binds to the neurotransmitter sites, weakly mimics the quaternary amine-aromatic physical interactions that normally occur between Carb and neurotransmitter binding site tyrosine and tryptophan residues -but not the Carb ester-nAChR This article has not been copyedited and formatted. The final version may differ from this version. By directly monitoring the structural changes that occur in the nAChR, FTIR detects a procaine induced conformational change that is not detected using traditional ligand binding approaches (Krodel et al., 1979) . FTIR provides a means of measuring local anesthetic binding affinity, and probes the detailed chemistry of local anesthetic-nAChR interactions.
Conformational effects of tetracaine on the nAChR in PC/PA/Chol 3:1:1. We used the same experimental approach to examine the effects of the local anesthetic, tetracaine, on the nAChR reconstituted into four different membrane environments. We first focused on the nAChR in membranes composed of PC/PA/Chol 3:1:1, as the nAChR in this environment fluxes cations in response to agonist binding (Fong and McNamee, 1986) . Carb difference spectra recorded from the nAChR reconstituted into PC/PA/Chol 3:1:1 (Fig. 2B, trace i,) are also similar to those recorded from the nAChR in native membranes (Ryan et al., 1996) . These and other data suggest the nAChR in PC/PA/Chol 3:1:1 membranes is stabilized in a functional resting state.
The Carb difference spectrum recorded at 10 µM concentrations of tetracaine, where tetracaine binding is restricted mainly to its non-competitive inhibitor site in the ion channel pore (K D = 1.5 µM) (Blanchard et al., 1979 ) is similar to those recorded in the absence of tetracaine ( Fig. 2A and 2B ), but exhibits subtle increases in the intensities of amide I and amide II marker bands that are diagnostic of the resting to desensitized conformational transition (EC 50 < 10 µM;
see Table 1 and Table 1S ). The most noticeable change is an increase in intensity to the left of the main amide I difference band centered near 1655 cm -1 . This increase in intensity leads to a separate positive peak centered near 1663 cm -1 (see also Fig. 2 
, supplemental information) and is
This article has not been copyedited and formatted. The final version may differ from this version. (Boyd and Cohen, 1980) , the fact that tetracaine increases the intensity near 1663 cm -1 to a greater extent than near 1655 cm -1 , has been interpreted in terms of the stabilization of a resting-like conformation (for a discussion of this point see Baenziger, 1999, Ryan et al., 2002) .
In contrast, higher concentrations of tetracaine lead to binding to the neurotransmitter sites (K D = 800 µM) and a reversal of the spectral changes observed at relatively low concentrations of tetracaine. There are decreases in the intensities of the amide I and amide II marker bands near 1663, 1655 and 1545 cm -1 , which are diagnostic of desensitization. As with procaine, the changes in intensity occur concomitant with the appearance of negative tetracaine vibrations, which result from the displacement of tetracaine from the neurotransmitter sites upon Carb binding (dashed line in Fig. 2B ). There are decreases in intensity of the putative tryptophan and tyrosine bands near 1620 and 1515 cm -1 , respectively, suggesting that tetracaine weakly mimics the quaternary amine-aromatic interactions that normally occur between Carb and binding site residues. Tetracaine shifts the tyrosine vibration up to 1519 cm -1 . As with procaine, the intensities and/or frequencies of the 1690/1668 cm -1 vibrations observed at high concentrations of tetracaine suggest that tetracaine does not interact with the nAChR residue that normally forms a hydrogen bond with the ester carbonyl of Carb in the esterophilic subsite.
This article has not been copyedited and formatted. The final version may differ from this version. Above 200 µM, tetracaine binds to the neurotransmitter sites, mimics some of the quaternary amine-aromatic interactions that normally occur between Carb and the nAChR, and appears to stabilize a desensitized conformation of the nAChR. Neurotransmitter site binding reverses the conformational effects that result from tetracaine binding to its non-competitive inhibitor site in the ion channel pore.
Conformational effects of tetracaine on the nAChR in PC.
The effects of tetracaine were next examined at the nAChR reconstituted into a membrane that does not stabilize a functional receptor. The nAChR in PC does not flux cations in response to agonist binding (Fong and McNamee, 1986) . Carb difference spectra recorded from the nAChR in PC exhibit a pattern of amide I and amide II marker band intensities (Fig. 3B , trace i) that is similar to the patterns observed in Carb difference spectra recorded in the presence of desensitizing local anesthetics (Ryan et al., 1996 ; also see trace iii of Fig. 1B, 2B , 4B, and 5B). The nAChR in PC cannot undergo the agonist-induced resting to desensitized conformational transition, possibly because it is already stabilized in a desensitized state. We were interested in testing whether low concentrations of tetracaine (<50 µM) could shift the "desensitized" nAChR in PC into a functional resting-like conformation.
Surprisingly, Carb difference spectra recorded from the nAChR in PC membranes in the presence of tetracaine at concentrations up to 50 µM are all essentially identical to those observed in the absence of tetracaine (Fig. 3B, traces i and ii) . Superimposition of the spectra shows that no dose dependent increase in intensity of any of the amide I or amide II difference bands indicative of desensitization can be detected (data not shown, but see This article has not been copyedited and formatted. The final version may differ from this version. At concentrations of tetracaine above 200 µM, negative tetracaine vibrations suggestive of tetracaine binding to the neurotransmitter sites are observed (dashed line in Fig. 3B ). These bands first appear at concentrations of tetracaine similar to those at which they appear in difference spectra recorded from the nAChR in PC/PA/Chol 3:1:1 membranes. At higher concentrations of tetracaine, however, the negative tetracaine bands are consistently weaker in the difference spectra recorded from the nAChR in PC than in PC/PA/Chol 3:1:1. Even at 2 mM tetracaine, the amount of tetracaine displaced upon Carb binding to the nAChR reaches only ~50% of that observed at 800 µM tetracaine in PC/PA/Chol 3:1:1. Further, tetracaine has minimal if any effect on the intensities of either the putative tryptophan or tyrosine vibrations.
The tyrosine vibration, which in PC membranes occurs near 1517 cm -1 , does not shift up in frequency upon tetracaine binding (see Fig. 6 ). Note also that the increase in intensity of the tyrosine vibration in PC membranes is weaker than in PC/PA/Chol 3:1:1 membranes. These results, which are discussed in more detail below, suggest an altered binding of tetracaine to the neurotransmitter sites in PC versus PC/PA/Chol 3:1:1 membranes.
Conformational effects of tetracaine on the nAChR in PC/PA 3:2 membranes.
The effects of tetracaine were next examined with the nAChR reconstituted into PC/PA 3:2 membranes. The Carb difference spectrum recorded in the absence of tetracaine exhibits a pattern of amide I and II marker bands that is close, but not identical to that observed in both PC/PA/Chol 3:1:1 and native membranes (Fig. 4B , trace i) (Baenziger et al., 2000; daCosta et al., 2002) . PA alone in a PC membrane is thus effective at stabilizing the nAChR in a functional state that undergoes Carb induced desensitization (Baenziger et al., 2000) .
Similar to the data obtained with the nAChR in PC/PA/Chol 3:1:1 membranes,
concentrations of tetracaine up to 50 µM where binding is restricted to its non-competitive
This article has not been copyedited and formatted. The final version may differ from this version. inhibitor site, lead to reproducible increases in the intensities of amide I and II marker bands indicative of desensitization (Fig. 4) . Specifically, there are slight increases in intensity near 1655 and 1545 cm -1 , and the appearance of new positive intensity near 1663 cm -1 (EC 50 < 10 µM; Table 1 and Table 1S ). The increase in intensity near 1663 cm -1 is clearly visible in spectra recorded at 5 µM tetracaine, and remains evident as a distinct peak in spectra recorded at 10, 25, 50, and 100 µM concentrations of tetracaine (see Fig. 4 of supplemental information).
Tetracaine binding to its non-competitive inhibitor site thus favors a resting-like conformation.
The presence of PA alone in a PC membrane is sufficient to impart sensitivity to tetracaine binding at its non-competitive inhibitor site.
At higher concentrations, tetracaine reverses the conformational effects that result from non-competitive inhibitor site(s) binding. There is a reduction in the intensities of all the amide I
and II marker bands indicative of the resting to desensitized conformational transition, the appearance of vibrational bands suggestive of binding to the neurotransmitter sites, and a decrease in the intensities of bands near 1620 and 1515 cm -1 , suggesting that tetracaine mimics the quaternary amine-aromatic interactions that occur between Carb and binding site residues.
Tetracaine shifts the frequency of the tyrosine vibration up to near 1519 cm -1 . Tetracaine binds to the neurotransmitter site and likely stabilizes the desensitized state.
As with the nAChR in PC/PA/Chol 3:1:1, the conformational effects of tetracaine at the nAChR in PC/PA 3:2 membranes are dependent upon the site of tetracaine binding. The presence of PA in the PC membrane is sufficient to stabilize the nAChR in a state that responds fully to tetracaine's sensitizing and desensitizing actions. We therefore examined the binding of the agonist analog, tetramethylamine (TMA), which binds the nAChR with lower affinity (equilibrium binding affinity is ≅0.5 mM; Akk and Auerbach, 1996) .
Conformational effects of tetracaine on the nAChR in PC/
Difference spectra recorded using 10 µM and 1 mM concentrations of TMA exhibit marked differences in intensity for the nAChR reconstituted in PC/PA/Chol 3:1:1 versus PC membranes, and at the two concentrations studied. TMA difference spectra recorded from the nAChR in PC/PA/Chol 3:1:1 membranes at TMA concentrations of 10 µM and 1 mM exhibit difference bands indicative of both TMA binding and the resting to desensitized conformational transition, but at 10 µM TMA the absolute intensities of the bands are roughly 30% of those observed in the spectra recorded at 1 mM TMA. Higher concentrations of TMA did not lead to additional levels of TMA binding. In contrast, the 10 µM TMA difference spectra recorded from the nAChR in PC membranes do not exhibit any difference bands detectable above the level of noise showing that TMA does not bind appreciably to the nAChR in PC at this concentration.
Protein difference bands are observed in difference spectra recorded using 1 mM TMA concentrations, most notably at 1620 cm -1 , but these are less than 25% as intense as those 
Discussion
Our data show that membrane lipid composition influences tetracaine action at the nAChR. Concentrations of tetracaine (<50 µM) consistent with non-competitive inhibitor site binding and the consequent stabilization of a resting conformation of the nAChR in native membranes also stabilize the nAChR in a resting or resting-like state in membranes composed of PC/PA 3:2 and PC/PA/Chol 3:1:1. In contrast, similar concentrations of tetracaine have no effect on nAChR conformational equilibria with the nAChR in PC and PC/Chol 3:2 membranes.
These observation are significant because increasing evidence indicates that neuronal nAChRs are associated with membrane rafts (Bruses et al., 2001; Roth and Berg, 2003; Zhu et al., 2006) .
As the lipid composition in rafts differs from that of the bulk membrane, our findings indicate that drug action at the nAChR, and other membrane proteins, could vary depending on whether the receptor is located in raft or non-raft environments. Changes in lipid composition during development and/or in disease states could alter drug action in vivo. Mechanistic studies of drug action at membrane protein targets must therefore take into account the membrane environment in which the target is imbedded.
The data also provide insight into the mechanisms by which lipids and local anesthetics influence nAChR function. Typically, the conformational effects of both lipids and local anesthetics are interpreted in terms of a two state model. In native membranes, the natural equilibrium between functional resting and non-functional desensitized conformations favors the resting state (~80% resting). In PC membranes, the nAChR does not flux cations or undergo an A second possibility is that the absence of the negatively charged PA reduces the partitioning of the positively charged tetracaine into the PC and PC/Chol 3:2 lipid bilayers (Table   2 ). If tetracaine accesses its non-competitive inhibitor site in the channel pore from the membrane, the low membrane concentrations of tetracaine in PC and PC/Chol 3:2 membranes would reduce the effective EC 50 for non-competitive inhibitor site(s) action. Even a modest decrease in apparent affinity might increase the effective EC 50 to a value above the EC 50 for action at the neurotransmitter sites. In such a case, the conformational effects of tetracaine in PC and PC/Chol 3:2 would be dominated by neurotransmitter site binding, as is observed with procaine ( Fig. 1) . Note that while direct access to the channel pore from the lipid bilayer is not evident in the atomic resolution model of the nAChR (Unwin, 2005) , internal breathing motions might create such a pathway. Most studies suggest that lipids influence nAChR function by modulating the equilibrium between resting and desensitized states with the non-activatable nAChR in PC reflecting a desensitized or desensitized-like conformation. Our data show that the neurotransmitter sites of the nAChR in PC are not desensitized in the presence of bound agonist. One possible explanation is that the nAChR in PC is locked in a resting conformation that does not undergo agonist-induced conformational change (Rankin et al., 1997) . The nAChR in PC, however, exhibits a chemical labeling pattern of the channel pore that is not consistent with a resting nAChR (daCosta et al, 2002) . The hydrogen exchange kinetics and thermal denaturation of the nAChR in PC are also not consistent with a resting conformation (Methot et al., 1995; daCosta et al, 2005) . The different lipid environments studied here likely influence local anesthetic action by stabilizing unique comformations that have altered sensitivities to local anesthetic action.
Conclusions
This study illustrates the complex interplay that can exist between lipid composition and drug action, and highlight some of the different mechanisms by which lipids might influence drug action at membrane protein targets. Stacked plot of Carb difference spectra recorded from the nAChR in the presence of (from top to bottom) 0, 10 µM, 100 µM, 200 µM, 400 µM, 600 µM, and 800 µM tetracaine. b) Representative spectra recorded at i) 0, ii) 10 µM, and iii) 800 µM tetracaine. The bottom spectrum iv) is a buffer subtracted spectrum of tetracaine in solution. The dashed line at 1605 cm -1 indicates the tetracaine vibrations in the Carb difference spectra. c) Dose response curves are as described in Fig. 1 , except that bands due to the increase in intensity of the vibration near 1663 cm -1 are also plotted (solid triangles). Bands due to the binding of tetracaine to the neurotransmitter sites (open squares) are also monitored at 1605 cm -1 . Note that the fit binding curves for the open circles and filled squares overlap.
Figure 3:
The conformational effects of tetracaine at the nAChR in PC. a) Stacked plot of Carb difference spectra recorded from the nAChR in the presence of (from top to bottom) 0, 5 µM, 10 µM, 50 µM, 100 µM, 200 µM, 400 µM, 600 µM, 800 µM, 1 mM, and 2 mM tetracaine.
b)
Representative spectra recorded at i) 0, ii) 10 µM, and iii) 800 µM tetracaine. The bottom spectrum iv) is a buffer subtracted spectrum of tetracaine in solution. The dashed line indicates the tetracaine vibrations in the Carb difference spectra. c) The dose response curve is for the binding of tetracaine to the neurotransmitter sites (open squares, monitored at 1605 cm -1 ). No dose dependent conformational changes were detected. The conformational effects of tetracaine at the nAChR in PC/PA 3:2. a) Stacked plot of Carb difference spectra recorded from the nAChR in the presence of (from top to bottom) 0, 5 µM, 10 µM, 25 µM, 50 µM, 100 µM, 200 µM, 300 µM, 400 µM, and 600 µM tetracaine. b) Representative spectra recorded at i) 0, ii) 10 µM, and iii) 600 µM tetracaine. The bottom spectrum iv) is a buffer subtracted spectrum of tetracaine in solution. The dashed line indicates the tetracaine vibrations in the Carb difference spectra. c) Dose response curves are as described in Fig. 2 . Figure 5: The conformational effects of tetracaine at the nAChR in PC/Chol 3:2. a) Stacked plot of Carb difference spectra recorded from the nAChR in the presence of (from top to bottom) 0, 10 µM, 50 µM, 100 µM, 200 µM, 300 µM, 400 µM, 500 µM, 600 µM, and 800 µM tetracaine. b) Representative spectra recorded at i) 0, ii) 10 µM, and iii) 800 µM tetracaine. The bottom spectrum iv) is a buffer subtracted spectrum of tetracaine in solution. The dashed line indicates the tetracaine vibrations in the Carb difference spectra. c) Dose response curves are as described in Fig. 2 . This article has not been copyedited and formatted. The final version may differ from this version. 
